Trials / Completed
CompletedNCT02641613
Retroclavicular Versus Supraclavicular Brachial Plexus Block for Hand and Forearm Surgery
The Efficacy of Retroclavicular Versus Supraclavicular Brachial Plexus Block in Patients Undergoing Forearm and Hand Surgery: a Randomized Controlled Double-blinded Trial.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Hôpital du Valais · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients will be randomized to one of two groups: 1. Supraclavicular group: supraclavicular brachial plexus block performed with the aid of ultrasound; 2. Retroclavicular group: retroclavicular brachial plexus block performed with the aid of ultrasound.
Detailed description
The study will be proposed to all patients undergoing formarm or hand surgery under brachial plexus block. Patients will be randomized to one of two groups The first group - supraclavicular group - will receive an ultrasound-guided brachial plexus block via the supraclavicular approach, by injection of 30 ml of a mixture of ropivacaine 0.5 % + mepivacaine 1 %. The second group - retroclavicular group - will receive an ultrasound-guided brachial plexus block via the retroclavicular approach, by injection of 30 ml of a mixture of ropivacaine 0.5 % + mepivacaine 1 %. Primary outcome is success rate at 30 minutes after the injection defined as loss of sensation to pinprick in the forearm and hand. Secondary outcomes are: needling time, time to first analgesic request, postoperative opioid consumption, pain scores at 12 and 24 hours postoperatively, block-related complications, and patient satisfaction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | retroclavicular block | retroclavicular block for forearm or hand surgery |
| PROCEDURE | supraclavicular block | supraclavicular block for forearm or hand surgery |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2018-05-01
- Completion
- 2018-05-01
- First posted
- 2015-12-29
- Last updated
- 2018-05-09
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02641613. Inclusion in this directory is not an endorsement.